Company intelligence / Profile preview

Renovis Surgical Technologies

Redlands, California, United Statesmedical.kyocera.com ↗

Ownership: Private
Employees: ~44
Development stage: Commercial

Overview

Renovis developed and commercialized a portfolio of FDA-cleared orthopedic and spinal implant systems using proprietary porous titanium structures to enhance bone integration. Their products were widely adopted prior to the acquisition by Kyocera. No ongoing clinical trials as the company has been absorbed into Kyocera.

Therapeutic areas: OtherRheumatology
Modalities: DeviceBiologicAdditive manufacturing/3D printing for medical devices
Industry: Implantable Medical Devices

Partnerships

Kyocera International, Inc.

Beyond the preview

Go deeper on Renovis Surgical Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Renovis Surgical Technologies.

Explore the full profile